BPG is committed to discovery and dissemination of knowledge
Cited by in CrossRef
For: Mestier L, Manceau G, Neuzillet C, Bachet JB, Spano JP, Kianmanesh R, Vaillant JC, Bouché O, Hannoun L, Karoui M. Primary tumor resection in colorectal cancer with unresectable synchronous metastases: A review. World J Gastrointest Oncol 2014; 6(6): 156-169 [PMID: 24936226 DOI: 10.4251/wjgo.v6.i6.156]
URL: https://www.wjgnet.com/1007-9327/full/v6/i6/156.htm
Number Citing Articles
1
Maikel Herbrink, Bastiaan Nuijen, Jan H.M. Schellens, Jos H. Beijnen. Variability in bioavailability of small molecular tyrosine kinase inhibitorsCancer Treatment Reviews 2015; 41(5): 412 doi: 10.1016/j.ctrv.2015.03.005
2
Jiefeng Zhao, Jinfeng Zhu, Rui Sun, Chao Huang, Rongfa Yuan, Zhengming Zhu. Primary tumor resection improves prognosis of unresectable carcinomas of the transverse colon including flexures with liver metastasis: a preliminary population-based analysisBMC Cancer 2021; 21(1) doi: 10.1186/s12885-021-08157-0
3
Jae Hyun Kim, Sol Jin, Min Ji Jeon, Hyun Yeb Jung, Sanghwan Byun, Kyoungwon Jung, Sung Eun Kim, Won Moon, Moo In Park, Seun Ja Park. Survival Benefit of Palliative Primary Tumor Resection Based on Tumor Location in Patients with Metastatic Colorectal Cancer: A Single-center Retrospective StudyThe Korean Journal of Gastroenterology 2020; 76(1): 17 doi: 10.4166/kjg.2020.76.1.17
4
Sunu Philip, Gabriel Bakula, Michael Jacobs, Vijay K. Mittal. The Management of Patients with Colorectal Cancer and Synchronous Liver Metastases or Indeterminate Liver Lesions: A Community Teaching Hospital ExperienceThe American Surgeon 2017; 83(1): 33 doi: 10.1177/000313481708300120
5
Jorine 't Lam‐Boer, Lydia G. Van der Geest, Cees Verhoef, Marloes E. Elferink, Miriam Koopman, Johannes H. de Wilt. Palliative resection of the primary tumor is associated with improved overall survival in incurable stage IV colorectal cancer: A nationwide population‐based propensity‐score adjusted study in the NetherlandsInternational Journal of Cancer 2016; 139(9): 2082 doi: 10.1002/ijc.30240
6
Ruba Hamed, Sam Marks, Helen Mcelligott, Roshni Kalachand, Hawa Ibrahim, Said Atyani, Greg Korpanty, Nemer Osman. Inoperable de novo metastatic colorectal cancer with primary tumour in situ: Evaluating discordant responses to upfront systemic therapy of the primary tumours and metastatic sites and complications arising from primary tumours (experiences from an Irish Cancer Centre)Molecular and Clinical Oncology 2021; 16(2) doi: 10.3892/mco.2021.2472
7
Peng Yuan, Jinhua Song, Fei Wang, Guangyu Zhu, Baoan Chen. Combination of TACE and Lenvatinib as a promising option for downstaging to surgery of initially unresectable intrahepatic cholangiocarcinomaInvestigational New Drugs 2022; 40(5): 1125 doi: 10.1007/s10637-022-01257-z
8
Balázs Pécsi, László Csaba Mangel. The Real-Life Impact of Primary Tumor Resection of Synchronous Metastatic Colorectal Cancer—From a Clinical Oncologic Point of ViewCancers 2024; 16(8): 1460 doi: 10.3390/cancers16081460
9
Anna Stickel, Ute Goerling. Psycho-OncologyRecent Results in Cancer Research 2018; 210: 163 doi: 10.1007/978-3-319-64310-6_10
10
Yuan Li, Silei Sui, Ajay Goel. Extracellular vesicles associated microRNAs: Their biology and clinical significance as biomarkers in gastrointestinal cancersSeminars in Cancer Biology 2024; 99: 5 doi: 10.1016/j.semcancer.2024.02.001
11
Han Shuwen, Wang Yangyanqiu, Chu Jian, Hu Boyang, Chen Gong, Zhuang Jing. Synergistic effect of sodium butyrate and oxaliplatin on colorectal cancerTranslational Oncology 2023; 27: 101598 doi: 10.1016/j.tranon.2022.101598
12
Tim van de Loo, Fabian Kütting, Hakan Alakus, Christiane J. Bruns. Resektion des Primarius beim Kolonkarzinom mit nichtresektabler MetastasierungDer Onkologe 2021; 27(6): 612 doi: 10.1007/s00761-021-00947-2
13
Erik Rasbach, Emrullah Birgin, Alexander Betzler, Nuh N. Rahbari, Christoph Reissfelder. Therapiestrategien beim synchron metastasierten Kolonkarzinomcoloproctology 2022; 44(3): 169 doi: 10.1007/s00053-022-00601-4
14
Levent Korkmaz, Hasan Şenol Coşkun, Faysal Dane, Bülent Karabulut, Mustafa Karaağaç, Devrim Çabuk, Senem Karabulut, Nuri Faruk Aykan, Hatice Doruk, Nilüfer Avcı, Nazım Serdar Turhal, Mehmet Artaç. Kras-mutation influences outcomes for palliative primary tumor resection in advanced colorectal cancer-a Turkish Oncology Group studySurgical Oncology 2018; 27(3): 485 doi: 10.1016/j.suronc.2018.05.032
15
Akihisa Matsuda, Takeshi Yamada, Satoshi Matsumoto, Seiichi Shinji, Ryo Ohta, Hiromichi Sonoda, Goro Takahashi, Takuma Iwai, Kohki Takeda, Kumiko Sekiguchi, Hiroshi Yoshida. Systemic Chemotherapy is a Promising Treatment Option for Patients with Colonic Stents: A ReviewJournal of the Anus, Rectum and Colon 2021; 5(1): 1 doi: 10.23922/jarc.2020-061
16
Shanu Jain, Reena Engineer, Vikas Ostwal, Anant Ramaswamy, Supriya Chopra, Ashwin Desouza, Shirley Lewis, Supreeta Arya, Prachi Patil, Avanish Saklani. Addition of short course radiotherapy in newly diagnosed locally advanced rectal cancers with distant metastasisAsia-Pacific Journal of Clinical Oncology 2021; 17(2) doi: 10.1111/ajco.13305
17
Nicolas Voizard, Tiffany Ni, Alex Kiss, Robyn Pugash, Michael Jonathon Raphael, Natalie Coburn, Elizabeth David. Small Particle DEBIRI TACE as Salvage Therapy in Patients with Liver Dominant Colorectal Cancer Metastasis: Retrospective Analysis of Safety and OutcomesCurrent Oncology 2022; 29(1): 209 doi: 10.3390/curroncol29010020
18
Ryan Margolis, Lokesh Basavarajappa, Junjie Li, Girgis Obaid, Kenneth Hoyt. Image-guided focused ultrasound-mediated molecular delivery to breast cancer in an animal modelPhysics in Medicine & Biology 2023; 68(15): 155012 doi: 10.1088/1361-6560/ace23d
19
J. Péron, P. Rousset, G. Passot. Strategia oncochirurgica della gestione delle metastasi epatiche di origine colorettaleEMC - Tecniche Chirurgiche Addominale 2020; 26(3): 1 doi: 10.1016/S1283-0798(20)44126-9
20
T.E. Madiba, F. Makumbi. Digestive Diseases in Sub-Saharan Africa2019; : 129 doi: 10.1016/B978-0-12-815677-3.00014-1
21
Weijie Pan, Kaijing Wang, Jiayong Li, Hanhua Li, Yuchan Cai, Min Zhang, Aili Wang, Yazhou Wu, Wei Gao, Wenhao Weng. Restoring HOXD10 Exhibits Therapeutic Potential for Ameliorating Malignant Progression and 5-Fluorouracil Resistance in Colorectal CancerFrontiers in Oncology 2021; 11 doi: 10.3389/fonc.2021.771528
22
Iu. V. Alimova, Yu. A. Shelygin, E. G. Rybakov. Palliative primary tumor resection in minimally symptomatic patients with colorectal cancer and synchronous unresectable metastases: when is it necessary? (systematic review)Koloproktologia 2022; 21(3): 99 doi: 10.33878/2073-7556-2022-21-3-99-110
23
Georgios D Lianos, Georgios K Glantzounis. Synchronous colorectal liver metastases: treatment dilemmas and hopes for improving oncological outcomesFuture Oncology 2016; 12(15): 1743 doi: 10.2217/fon-2016-0060
24
Floris S. Verheij, Jonathan B. Yuval, Niels F.M. Kok, Sabrina T. Lin, Li-Xuan Qin, Dana M. Omer, Hannah M. Thompson, Iris H. Wei, Maria Widmar, Emmanouil P. Pappou, Martin R. Weiser, Garrett M. Nash, J. Joshua Smith, Philip B. Paty, Geerard L. Beets, Julio Garcia-Aguilar. Nonoperative management of the primary tumor in patients with unresectable stage IV colon cancer treated with systemic chemotherapy: Higher complication rates for left-sided colon tumorsEuropean Journal of Surgical Oncology 2024; 50(1): 107294 doi: 10.1016/j.ejso.2023.107294
25
Shu-wen Liao, Jie-qun Zhan, Chu-tian Liu, Hai-tao Yu, Min-jie Wen. Survival Benefit of Primary Tumor Resection Combined With Chemotherapy in Patients With Unresectable Colorectal Mucinous Adenocarcinoma With Liver MetastasisAmerican Journal of Clinical Oncology 2024; 47(1): 30 doi: 10.1097/COC.0000000000001055
26
Junge Bai, Ming Yang, Zheng Liu, Sergey Efetov, Cuneyt Kayaalp, Audrius Dulskas, Darcy Shaw, Xishan Wang. Primary tumor resection in colorectal cancer patients with unresectable distant metastases: a minireviewFrontiers in Oncology 2023; 13 doi: 10.3389/fonc.2023.1138407
27
S D Nelen, M van Putten, V E P P Lemmens, K Bosscha, J H W de Wilt, R H A Verhoeven. Effect of age on rates of palliative surgery and chemotherapy use in patients with locally advanced or metastatic gastric cancerBritish Journal of Surgery 2017; 104(13): 1837 doi: 10.1002/bjs.10621
28
Fangfang Sun, Weiwei Liang, Jing Qian. The identification of CRNDE, H19, UCA1 and HOTAIR as the key lncRNAs involved in oxaliplatin or irinotecan resistance in the chemotherapy of colorectal cancer based on integrative bioinformatics analysisMolecular Medicine Reports 2019;  doi: 10.3892/mmr.2019.10588
29
Jiefeng Zhao, Jinfeng Zhu, Chao Huang, Rongfa Yuan, Zhengming Zhu. Impact of primary tumor resection on the survival of patients with unresectable colon cancer liver metastasis at different colonic subsites: a propensity score matching analysisActa Chirurgica Belgica 2023; 123(2): 132 doi: 10.1080/00015458.2021.1956799
30
Tsuyoshi Konishi, Miguel A. Rodriguez-Bigas. Primary Tumor Resection in Colorectal Cancer with Unresectable Synchronous Metastasis: Time to Reconsider the Role of the SurgeonAnnals of Surgical Oncology 2022; 29(1): 1 doi: 10.1245/s10434-021-10949-4
31
Fang-fang Qi, Yunyao Yang, Haowen Zhang, Hongping Chen. Long non-coding RNAs: Key regulators in oxaliplatin resistance of colorectal cancerBiomedicine & Pharmacotherapy 2020; 128: 110329 doi: 10.1016/j.biopha.2020.110329
32
Yefei Shu, Ling Xu, Wei Yang, Xiaofeng Xu, Song Zheng. Asymptomatic Primary Tumor Resection in Metastatic Colorectal Cancer: A Systematic Review and Meta-AnalysisFrontiers in Oncology 2022; 12 doi: 10.3389/fonc.2022.836404
33
S Kader, Y Moodley, TE Madiba. The clinicopathological spectrum and treatment outcomes in metastatic colorectal cancer in the KwaZulu-Natal province of South AfricaSouth African Journal of Surgery 2023; 61(2): 14 doi: 10.36303/SAJS.3316
34
Fotios Loupakis, Giulia Maddalena, Ilaria Depetris, Sabina Murgioni, Francesca Bergamo, Angelo Paolo Dei Tos, Massimo Rugge, Giada Munari, Andrew Nguyen, Christopher Szeto, Vittorina Zagonel, Sara Lonardi, Matteo Fassan. Treatment with checkpoint inhibitors in a metastatic colorectal cancer patient with molecular and immunohistochemical heterogeneity in MSI/dMMR statusJournal for ImmunoTherapy of Cancer 2019; 7(1) doi: 10.1186/s40425-019-0788-5
35
Kaihong Mi, Matthew F. Kalady, Cristiano Quintini, Alok A. Khorana. Integrating Systemic and Surgical Approaches to Treating Metastatic Colorectal CancerSurgical Oncology Clinics of North America 2015; 24(1): 199 doi: 10.1016/j.soc.2014.09.006
36
George J. Chang. Primary Tumor Resection in Colorectal Cancer With Synchronous Unresectable Metastasis: Time to End the Debate?Journal of Clinical Oncology 2021; 39(10): 1095 doi: 10.1200/JCO.21.00057
37
Shih-Jung Lo, Shu-Huan Huang, I-Li Lai, Yih-Jong Chern, Yu-Jen Hsu, Chun-Kai Liao, Ching-Chung Cheng, Wen-Sy Tsai, Pao-Shiu Hsieh, Jeng-Fu You. Upfront primary tumor resection versus upfront systemic therapy for metastatic colorectal cancer: a systematic review and meta-analysisInternational Journal of Colorectal Disease 2023; 38(1) doi: 10.1007/s00384-023-04483-w
38
Wenlong Du, Xiaoping Yang, Shenfu He, Jia Wang, Yuanxian Guo, Bangguo Kou, Yongjie Jiang, Pan Bian, Bingtai Li, Lanning Yin. Novel hyaluronic acid oligosaccharide-loaded and CD44v6-targeting oxaliplatin nanoparticles for the treatment of colorectal cancerDrug Delivery 2021; 28(1): 920 doi: 10.1080/10717544.2021.1914777
39
J. Péron, P. Rousset, G. Passot. Estrategia oncoquirúrgica para el tratamiento de las metástasis hepáticas de origen colorrectalEMC - Técnicas Quirúrgicas - Aparato Digestivo 2020; 36(3): 1 doi: 10.1016/S1282-9129(20)43993-5